Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.99 USD | +1.79% | +6.12% | -15.11% |
Jun. 24 | Transcript : Aprea Therapeutics, Inc. - Special Call | |
Jun. 17 | Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor APR-1051 | CI |
- Stock Market
- Equities
- APRE Stock
- News Aprea Therapeutics, Inc.
- MarketScreener Strategies